Our results demonstrate that CRC patients with high SLC10A3 expression experienced shorter survival times and a higher likelihood of disease progression, highlighting SLC10A3 as an independent risk factor for survival. The gene discussed is SLC10A3; the disease is colorectal carcinoma.